The turnover per employee in the biotechnology research and experimental development sector in Sweden is projected to exhibit steady growth from 2024 to 2028. In 2023, the value stood at 128.7 thousand euros. The forecasted data shows an incremental rise from 129.6 thousand euros in 2024 to 133.1 thousand euros in 2028. Year-on-year increases are relatively modest, ranging between 0.7% to 0.8% per annum. Over the past two years, the growth has been consistent at around 0.7-0.8% annually, indicating a stable upward trend. The Compound Annual Growth Rate (CAGR) over the next five years averages approximately 0.8% per year.

Future trends to watch for:

Technological advancements that can accelerate productivity and higher turnover per employee.
Increased investment in research and development to sustain and boost growth rates.
Potential policy changes that could either positively or negatively influence the sector's growth.
Global economic conditions which may impact funding and investments within the biotechnology sector.